Publications
179
Citations
3,257
Est. group size
~26
Recurring co-author estimate
Active years
23
Publishing since 2004
Gregory K. Behbehani's research focuses on blood cancers, particularly acute myeloid leukemia and BCR/ABL-positive leukemias, using advanced single-cell profiling techniques such as mass cytometry to study how leukemia cells respond to treatment and evade the immune system. His work also extends to studying immune cells (like macrophages) in brain tumors and how RNA molecules regulate DNA damage repair in cancer cells. This research aims to better understand cancer biology at the single-cell level to inform new therapeutic strategies.
Publication output has grown substantially over the past decade, rising from a handful of papers per year in 2017-2018 to over 30 in recent years, though with some year-to-year fluctuation.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- <i>circPCMTD1</i> : a protein-coding circular RNA that regulates DNA damage response in <i>BCR/ABL</i> <i>1</i> -positive leukemias
Blood · 2026
- <i>In vitro</i> generated macrophages reflect the immunosuppressive phenotype of <i>in vivo</i> glioblastoma-associated macrophages
OncoImmunology · 2026
- <i>circPCMTD1</i> : A protein-coding circular RNA that regulates DNA damage response in <i>BCR/ABL</i> -positive leukemias
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- A Protein-Coding Circular RNA That Regulates DNA Damage Response in <i>BCR</i>::<i>ABL</i>-Positive Leukemias
Blood · 2024
- Mass Cytometry as a Tool for Investigating Senescence in Multiple Model Systems
Cells · 2023
- 406 Reprogramming the glioma immunosuppressive tumor microenvironment with engineered myeloid cells that release IL-2 to delay malignant progression
Regular and Young Investigator Award Abstracts · 2023
- Supplementary Figures 1 - 8 from Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy
2023
- Supplementary Figure 9 from Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy
2023
- Supplementary Table 5 from Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy
2023
- Supplementary Figure Legends from Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy
2023
- Supplementary Table 4 from Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy
2023
- Supplementary Tables 1 - 3 from Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy
2023
- Supplementary Methods from Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy
2023
- Supplementary Figure Legends from Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy
2023
- Supplementary Table 4 from Mass Cytometric Functional Profiling of Acute Myeloid Leukemia Defines Cell-Cycle and Immunophenotypic Properties That Correlate with Known Responses to Therapy
2023
- Blood×20
- Transplantation and Cellular Therapy×6
- bioRxiv (Cold Spring Harbor Laboratory)×6
- Journal of Clinical Oncology×6
- Molecular Therapy Oncology×5
- Bradley W. Blaser
Medicine · The Ohio State University
- Marie Goulard
Medicine · The Ohio State University
- Wenjie Cai
Medicine · Indiana University
- Sumithra Vasu
Medicine · The Ohio State University
- Sumithira Vasu
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile